Navigation Links
VAP(R) Cholesterol Test Highlighted in Groundbreaking Book on Longevity

BIRMINGHAM, Ala., July 7 /PRNewswire/ -- The VAP(R) Cholesterol Test recently gained the honor of being a component in one of nine steps to a longer life. TRANSCEND: Nine Steps to Living Well Forever (Rodale, 2009) by anti-aging authority Terry Grossman, M.D., and world-renowned futurist Ray Kurzweil, identifies the VAP advanced lipid profile as one of the future technologies in cardiovascular risk assessment.

Grossman, the book's co-author and medical director of The Grossman Wellness Center ( in Golden, Colo., describes how America's greatest health threat is lack of early detection and lack of testing. Grossman, who uses the VAP Test at his Denver-area practice, said he believes that virtually all disease is discoverable and, with an aggressive approach, treatable.

The VAP (Vertical Auto Profile) Test is manufactured by Atherotech, Inc., a cardio-diagnostic company based in Birmingham, Ala. Company President Mike Mullen said inclusion of the VAP Test in the book furthers the validity of the test and its ability to identify cardiovascular risks far better than the standard cholesterol test.

"By highlighting the VAP Test in this powerful book on health and longevity, the authors recognize the unique cardiovascular assessment that our test provides to proactive, preventive-minded physicians and their patients," Mullen said.

TRANSCEND is described as a practical, easy-to-understand application of the breakthrough scientific findings on life extension. Under the heading of "How To Keep Your Heart Beating" in the chapter entitled "Blood Tests For Early Detection Of Cardiovascular Disease," the authors state:

         "When a standard panel is run, the total cholesterol, HDL and
         triglycerides are measured, while the LDL is calculated from the
         other results. In the VAP test, LDL is measured directly, providing
         much more accurate information than a calculated value.

         VAP also measures lipoprotein(a), IDL, and VDL, risk factors found to
         be more important than total cholesterol and LDL. Finally, VAP
         fractionates or splits HDL, the beneficial form of cholesterol, into
         HDL-2 and HDL-3 subunits. HDL-2 is much more protective than HDL-3.
         Low HDL-2 is a significant risk factor for cardiovascular disease."

The TRANSCEND authors urge people to take advantage of the accelerating developments in biotechnology and offer everything from updates on relevant research to tips on talking to your doctor about cutting-edge testing.

The VAP Test reports 20 separate components of blood cholesterol as opposed to four in a standard cholesterol test. The test can identify a far greater number of lipid abnormalities -- the No. 1 risk factor for heart disease -- than the standard cholesterol test and now reports apoAI and the apoB/apoAI ratio at no added cost.

People with a family history or an existing condition of diabetes, high blood pressure or heart disease -- or who are already taking cholesterol-lowering medication -- are candidates for the comprehensive VAP Test. In addition, those who don't score within the desirable ranges of the standard cholesterol test (i.e. those with triglycerides > 150, HDL < 40, LDL >130, total cholesterol > 200) should also opt for the more detailed VAP Test.

The VAP Test is available nationwide and covered by most insurance providers, including Medicare and Medicaid. For more information call 877.901.8510 or visit

About Atherotech, Inc.

Atherotech is a cardio-diagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit

SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genes Linked to Cholesterol in Cells Are Identified
2. Kardea Enhances Medical Nutrition System for Cholesterol Lowering
3. Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease
4. Cholesterol Drugs May Help in Cardiac Emergency
5. Managing Blood Pressure, Cholesterol Cuts Stroke Risk
6. Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke
7. PDAs, more education help doctors follow cholesterol treatment guidelines
8. New Study Shows Fish Oil Improves Cholesterol Levels in Professional Football Players
9. Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month
10. Acetaminophen, Cholesterol Drugs May Help Fight Stroke
11. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest ... Integration ,” addresses a main “pain point” for merging or aligning healthcare provider ... a deal is signed. This quick-read guidance suggests that failing to recognize ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., ... largest order to date. , The order will be from the China Disabled ... Cochlear Implant System is an effective solution for children and adults suffering from ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... companies, announced today that it has officially launched a sleek, mobile-ready and user-centric ... that his company’s new website clearly outlines the benefits that its SEO services ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... MN (PRWEB) , ... December 01, 2015 , ... ... is the latest carrier to offer individual vision insurance plans on ... the unique ability to rate and review products, allowing consumers to compare, quote ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015  InCarda Therapeutics, Inc. (InCarda), a privately-held ... therapies for cardiovascular conditions via the inhalation route, today ... Australia . InCarda is planning to ... Australia in the first half of 2016. ... centers in Adelaide and Melbourne.  ...
(Date:12/1/2015)... ) has ... Systems/Personal Emergency Response System (PERS) Market by Type, ... report to their offering. --> ... "Medical Alert Systems/Personal Emergency Response System (PERS) ... - Global Forecas" report to their offering. ...
(Date:12/1/2015)... Texas , Dec. 1, 2015 /PRNewswire/ ...  announced today that top-line data from its ... telotristat etiprate in treating carcinoid syndrome in ... with the clinical benefit observed in its ... designed as a companion to TELESTAR primarily ...
Breaking Medicine Technology: